ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years
Wenpeng Huang
Matched on ORCID iD 0000-0001-7405-3816; OpenAlex author ID A5102915818. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- ImmunoPET imaging of c-Met using a nanobody-based tracer [68Ga]Ga-NOTA-PFCM01 in pancreatic ductal adenocarcinoma models and non-human primates. Co-author DOI 10.1007/s00259-025-07441-6↗
- Noninvasive Evaluation of Trop2 Expression Using 64Cu-NOTA-Trodelvy-F(ab')2 in Gastric and Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.5c01223↗
- Pancreatic cancer detected with 18F-FDG PET/CT in a case of IgG4-related disease. Co-author DOI 10.17235/reed.2023.9870/2023↗
- Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. Co-author DOI 10.1007/s00259-022-05954-y↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei Kang · 4 shared papers, 2022–2025 · strength 0.91
- Paper Pancreatic cancer detected with 18F-FDG PET/CT in a case of IgG4-related disease. DOI 10.17235/reed.2023.9870/2023↗
- Paper ImmunoPET imaging of c-Met using a nanobody-based tracer [68Ga]Ga-NOTA-PFCM01 in pancreatic ductal adenocarcinoma model… DOI 10.1007/s00259-025-07441-6↗
- Paper Noninvasive Evaluation of Trop2 Expression Using 64Cu-NOTA-Trodelvy-F(ab')2 in Gastric and Pancreatic Cancer. DOI 10.1021/acs.molpharmaceut.5c01223↗
- Xinyao Sun · 1 shared paper, 2025 · strength 0.26
- Tianyao Wang · 1 shared paper, 2025 · strength 0.26
- Weibo Cai · 1 shared paper, 2025 · strength 0.25
- Xu Yang · 1 shared paper, 2022 · strength 0.14
- Cuicui Li · 1 shared paper, 2022 · strength 0.14
- Jigang Yang · 1 shared paper, 2022 · strength 0.14
- Qingfang Miao · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.